Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513903 · ClinicalTrials.gov registry record · Phase 3
Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases
A Phase 3 study, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 3
- Development phase
- 954
- Enrollment target
NCT00513903: Completed Phase 3 study, sponsored by University of Iowa.
NCT00513903 is a Phase 3 study that has completed, run by University of Iowa. The registered enrollment target is 954 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00513903, a Phase 3 study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 954 participants
- Enrollment target
Study Summary
This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visits in vulnerable patients with cardiovascular disease, pulmonary disease or diabetes.
Interventions
- BEHAVIORAL Minimal intervention
- BEHAVIORAL Enhanced Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 954 participants |
| Start Date | 2008-03 |
| Est. Completion | 2012-10 |
| Phase | Phase 3 |
What the finished NCT00513903 record still lists
NCT00513903 is an interventional study that assigns participants to a tested intervention. The registered 954 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% higher).
The record links to 0 conditions, and to 2 interventions - of which Minimal intervention is the first listed.
NCT00513903 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00513903 about?
NCT00513903 is a clinical study titled "Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases". This study will test whether enhanced continuity of pharmacy care that includes increased communication between inpatient and outpatient settings will improve the appropriateness of medication therapy and reduce the number of serious adverse drug events, hospitalizations and unscheduled office visit...
What is the current status of trial NCT00513903?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 954 participants. The study started on 2008-03. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00513903?
The interventions under investigation include: Minimal intervention (BEHAVIORAL), Enhanced Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00513903?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00513903's enrollment target sits among peer trials
954 333rd of 2000 higher than 1,668 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06225596 · 956 participants · Phase 2
Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)
- NCT04375033 · 952 participants · Phase 4
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
- NCT06259669 · 958 participants
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
- NCT03784924 · 950 participants
EDRN Prostate MRI Biomarker Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia